paricalcitol (Q22025): Difference between revisions
Jump to navigation
Jump to search
Created claim: medical condition treated (P663): secondary hyperparathyroidism (Q22016) |
Added link to [en]: Paricalcitol |
||
| (2 intermediate revisions by the same user not shown) | |||
| Property / medical condition treated | |||
| Property / medical condition treated: kidney failure / rank | |||
Normal rank | |||
| Property / medical condition treated | |||
| Property / medical condition treated: chronic renal insufficiency / rank | |||
Normal rank | |||
| links / en / name | links / en / name | ||
Latest revision as of 23:12, 12 April 2024
chemical compound
- Zemplar®
- 19-Nor-1alpha,25-dihydroxyvitamin D2
- Paricalcitol
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | paricalcitol |
chemical compound |
|
Statements
C₂₇H₄₄O₃
0 references